Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$479M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$415M |
| 3 |
Apple
AAPL
|
+$313M |
| 4 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$292M |
| 5 |
JPMorgan Chase
JPM
|
+$282M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$393M |
| 2 |
American Tower
AMT
|
+$282M |
| 3 |
Wells Fargo
WFC
|
+$268M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$241M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.56% |
| 2 | Healthcare | 12.1% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $1.57M | ﹤0.01% |
63,306
-140,423
| -69% | -$3.37M |
|
2677
Astronics
ATRO
$4.33B
| $1.57M | ﹤0.01% |
178,315
+84,710
| +90% | +$662K |
|
2678
Fulgent Genetics
FLGT
$515M
| $1.57M | ﹤0.01% |
97,935
-29,490
| -23% | -$452K |
|
2679
Voyager Therapeutics
VYGR
$197M
| $1.56M | ﹤0.01% |
123,509
+28,101
| +29% | +$327K |
|
2680
US Commodity Index
USCI
$378M
| $1.56M | ﹤0.01% |
58,635
+1,482
| +3% | +$38.8K |
|
2681
WisdomTree US MidCap Fund
EZM
$955M
| $1.56M | ﹤0.01% |
47,736
-3,969
| -8% | -$121K |
|
2682
Infosys
INFY
$49.8B
| $1.56M | ﹤0.01% |
160,867
-16,186
| -9% | -$145K |
|
2683
United States Oil Fund
USO
$1.8B
| $1.55M | ﹤0.01% |
55,286
+12,517
| +29% | +$342K |
|
2684
Pearson
PSO
$9.7B
| $1.55M | ﹤0.01% |
213,959
-60,938
| -22% | -$380K |
|
|
PMM
2685
Franklin Managed Municipal Income Trust
PMM
$270M
| $1.54M | ﹤0.01% |
210,042
-132,377
| -39% | -$936K |
|
2686
VanEck Oil Services ETF
OIH
$1.96B
| $1.54M | ﹤0.01% |
12,614
+7,099
| +129% | +$795K |
|
2687
Ultragenyx Pharmaceutical
RARE
$2.65B
| $1.54M | ﹤0.01% |
19,667
-6,420
| -25% | -$425K |
|
2688
Collegium Pharmaceutical
COLL
$834M
| $1.53M | ﹤0.01% |
87,651
+1,383
| +2% | +$27.1K |
|
2689
Sociedad Química y Minera de Chile
SQM
$20.4B
| $1.53M | ﹤0.01% |
58,850
+18,566
| +46% | +$446K |
|
2690
BridgeBio Pharma
BBIO
$16.4B
| $1.53M | ﹤0.01% |
46,802
-11,690
| -20% | -$356K |
|
2691
The RealReal
REAL
$1.36B
| $1.52M | ﹤0.01% |
119,057
+24,781
| +26% | +$295K |
|
|
HPI
2692
John Hancock Preferred Income Fund
HPI
$434M
| $1.52M | ﹤0.01% |
77,603
+9,977
| +15% | +$180K |
|
2693
ENI
E
$79.7B
| $1.51M | ﹤0.01% |
78,618
+3,637
| +5% | +$69.9K |
|
|
ZUO
2694
DELISTED
Zuora, Inc.
ZUO
| $1.51M | ﹤0.01% |
+118,908
| New | +$1.32M |
|
|
MQT
2695
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $1.51M | ﹤0.01% |
118,559
+81,299
| +218% | +$1,000K |
|
2696
Peapack-Gladstone Financial
PGC
$821M
| $1.51M | ﹤0.01% |
80,724
-31,282
| -28% | -$554K |
|
|
AZEK
2697
DELISTED
The AZEK Co
AZEK
| $1.51M | ﹤0.01% |
+47,321
| New | +$1.44M |
|
2698
Ormat Technologies
ORA
$6.97B
| $1.51M | ﹤0.01% |
23,725
+441
| +2% | +$28.9K |
|
|
EMF
2699
Templeton Emerging Markets Fund
EMF
$332M
| $1.5M | ﹤0.01% |
109,644
+18,377
| +20% | +$231K |
|
2700
BlackRock Enhanced Global Dividend Trust
BOE
$694M
| $1.5M | ﹤0.01% |
159,072
-23,835
| -13% | -$217K |
|
Similar funds
Ameriprise's Q2 2020 Portfolio in Review
As of Q2 2020, Ameriprise held 3,808 positions worth $233B, up 23% from $190B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q2 2020 filing shows 183 new, 1,548 increased, 1,847 reduced and 139 closed positions. Its largest new stake was Carrier Global: 9,308,867 shares worth $207M. The largest sale was Verizon, an estimated $393M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2020 buy was Carrier Global: 9,308,867 shares worth $207M.
- Ameriprise added most to TE Connectivity in Q2 2020, an estimated $479M increase.
- Ameriprise's biggest Q2 2020 reduction was Verizon, cutting an estimated $393M.
- Ameriprise fully exited Allergan plc in Q2 2020, selling an estimated $124M.
- Ameriprise's ten largest holdings make up 17% of its $233B portfolio in Q2 2020.
- Ameriprise opened 183 new positions and closed 139 in Q2 2020.
- Ameriprise's portfolio value rose 23% quarter-over-quarter to $233B.
Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.